FDA - HealthQuill

The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that affects plasma cells made in the bone marrow, according to a company statement.

US regulator approves Pfizer’s Elrexfio to treat multiple myeloma

HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.

by HealthQuill
August 15, 2023
0 Comments

The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat multiple myeloma.

Drugs Health Pharma

USFDA green lights Janssen’s Talvey to treat multiple myeloma

HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.

by HealthQuill
August 11, 2023
0 Comments

Sweden’s Getinge Group is recalling its cardiosave hybrid and rescue intra-aortic balloon pumps after the FDA initiated a most serious recall, Class 1.

Drugs Health Pharma

Getinge Group recalls intra-aortic pumps due to faulty power system

HQ Team August 11, 2023: Sweden’s Getinge Group is recalling its cardiosave hybrid and rescue intra-aortic balloon pumps after the FDA initiated a.

by HealthQuill
August 11, 2023
0 Comments

India’s Lupin Ltd. has the USFDA nod for making a generic birth control pill, according to a company statement.

Drugs Health Pharma

India’s Lupin gets FDA nod to make generic oral contraceptive

HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the.

by HealthQuill
August 2, 2023
0 Comments

Harm Reduction Therapeutics’s RiVive has become the second opioid overdose reversal drug the FDA allows without a prescription in the US.

Drugs Health Pharma

USFDA gives nod for second opioid overdose reversal drug ReVive

HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid.

by HealthQuill
July 30, 2023
0 Comments

Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement

Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,.

by HealthQuill
July 29, 2023
0 Comments

Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved by the FDA for people between 18 and 65 years.

Drugs Health Pharma

US-based Emergent’s anthrax vaccine gets FDA clearance

HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.

by HealthQuill
July 24, 2023
0 Comments

US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious viral skin disease, the company announced.

Drugs Health Pharma

USFDA green lights Verrica’s drug to treat contagious viral skin disease

HQ Team July 24, 2023: US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious.

by HealthQuill
July 24, 2023
0 Comments

Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.

Drugs Health Pharma

Eli Lilly: Alzheimer’s test drug slows cognitive decline in early stages

HQ Team July 18, 2023: Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of.